+ Main Category
+ Tell a Friend
Fill out the information below to email a friend a brief note about 'Pomology: Fruit Cultivation and Production'
+ Top 10
+ Directory Statistics
Links: 1182
Categories: 54
Registered Users: 178
Mailing List Subscribers: 24
+ Pagerank Statistics
+ Join Mailing List
Joining mailing list will entitle you to receive occasional emails informing you of news and updates to the site and any special offers that may be of interest to you.
Research > Chapter 10016
Bookmarks
Interleukin-4 overcomes negative effect cyclic AMP accumulation antigen receptor induced B lymphocytes.
Interleukin-4 plays dominant function Th1-or Th2-like responses primary immune answer hapten penicillin.
Interleukin-4 potentiates voltage-activated Ca-currents Lymnaea neurons.
Interleukin-4 prevents mortality acute chronic murine peritonitis induces accelerated tumor necrosis factor-alpha answer.
Interleukin-4 prevents spontaneous in-vitro apoptosis chronic lymphatic leukaemia sensitizes B-CLL cells melphalan cytotoxicity.
Interleukin-4 primes human mononuclear phagocytes enhanced chemiluminescence response-synergism interferon-alpha.
Interleukin-4 priming enhances target human complement-mediated cytotoxicity CLL.
Interleukin-4 production human alveolar macrophages.
Interleukin-4 production malignant cell line HUT78.
Interleukin-4 production Epstein-Barr Virus-transformed B cell lines peripheral mononuclear cells patients atopic dermatitis.
Interleukin-4 production asthmatic patients allergen immunotherapy. study.
Interleukin-4 promoter polymorphisms. genetic prognostic factor survival metastatic renal cell carcinoma.
Interleukin-4 promotes human CD8(+) T cell expression CCR7.
Interleukin-4 rapidly down-modulates macrophage colony-stimulating factor receptor murine macrophages.
Interleukin-4 receptor alpha chain ITIM motif mutant mice potentiate stat6 activation IgE production.
Interleukin-4 receptor alpha chain STAT6 signaling inhibit gamma interferon Th2 cytokine expression schistosome granulomas.
Interleukin-4 receptor epidermal growth factor receptor expression colorectal cancer.
Interleukin-4 receptor blockade prevents airway responses stimulated antigen challenge mice.
Interleukin-4 receptor expression human B cells - Functional examination human interleukin-4 toxin, DAB-389IL-4.
Interleukin-4 receptor expression vivo human AIDS-related Kaposi's sarcoma.
Interleukin-4 receptor expression AIDS-associated Kaposi's sarcoma cells targeting chimeric protein comprised circularly permuted interleukin-4 Pseudomonas exotoxin.
Interleukin-4 receptor signaling pathways asthma pathogenesis.
Interleukin-4 receptor-Stat6 signaling in murine infections with a tissue-dwelling nematode parasite
Interleukin-4 receptor-directed cytotoxin therapy AIDS-associated Kaposi's sarcoma tumors xenograft model.
Interleukin-4 receptors expressed tumor cells serve target anticancer therapy chimeric Pseudomonas exotoxin.
Interleukin-4 regulates connective tissue growth factor expression human lung fibroblasts.
Interleukin-4 regulates nitric oxide production normal human monocytes.
Interleukin-4 regulates proteoglycan-induced arthritis specifically suppressing innate immune answer.
Interleukin-4 regulation cytokine-induced HIV1 interleukin-8 expression promocytic U1 cells concentration- cytokine-dependent.
Interleukin-4 regulation cytokine-induced HIV1 interleukin-8 expression promonocytic U1 cells concentration- cytokine-dependent.
Interleukin-4 regulation human monocyte macrophage interleukin-10 interleukin-12 production. Role functional interleukin-2 receptor gamma-chain.
Interleukin-4 secretion allograft fails affect allograft-specific interleukin-4 answer vitro.
Interleukin-4 selectively inhibits interleukin-2 secretion lipopolysaccharide-activated dendritic cells.
Interleukin-4 signals regulating CD23 gene expression human B cells - Protein kinase C-independent signaling pathways.
Interleukin-4 stimulates Pro-alpha-1collagen gene expression cultured human osteoblast-like cells.
Interleukin-4 stimulates androgen-independent growth LNCaP human prostate cancer cells.
Interleukin-4 supports interleukin-12-induced proliferation interferon-gamma secretion human activated lymphoblasts T helper type 1 cells.
Interleukin-4 suppresses IL-1-induced expression matrix metalloproteinase-3 human gingival fibroblasts.
Interleukin-4 suppresses antifungal activity human mononuclear phagocytes Candida albicans association decreased absorption blastoconidia.
Interleukin-4 suppresses inflammatory cytokine gene transcription porcine macrophages.
Interleukin-4 suppresses enhancement ceramide synthesis cutaneous permeability barrier functions stimulated tumor necrosis factor-alpha interferon-gamma human epidermis.
Interleukin-4 suppresses expression macrophage NADPH oxidase heavy chain subunit (gp91-phox).
Interleukin-4 suppression interleukin-1-induced transcription collagenase (MMP-1) stromelysin 1 (MMP-3) human synovial fibroblasts.
Interleukin-4 therapy psoriasis induces Th2 responses improves human autoimmune disease.
Interleukin-4 transgenic mice develop glomerulosclerosis independent immunoglobulin deposition.
Interleukin-4 transgenic mice tolerant background vulnerable Leishmania major infection.
Interleukin-4 treatment restores cellular immunity after ethanol exposure and burn injury.
Interleukin-4 up-regulates T-tropic human immunoinsufficiency virus type 1 transcription primary CD4+ CD38+ T-lymphocyte subset.
Interleukin-4 upregulates heat shock protein Hsp90-alpha enhances transcription reporter gene coupled single heat shock element.
Interleukin-4 weakens host resistance pulmonary disseminated cryptococcal infection attributable combined cure interferon-gamma-inducing cytokines.
Interleukin-4(IL-4) IL-13 enhance ADAM33 gene expression human lung fibroblasts.
Interleukin-4, -5 -6 tumor necrosis factor-alpha normal asthmatic airways - Proof human mast cell source cytokines.
Interleukin-4, inhibitor cartilage breakdown bovine articular cartilage explants.
Interleukin-4, immunoglobulin E immunoglobulin A resistance re-infection Schistosoma haematobium chemotherapy.
Interleukin-4, immunoglobulin E immunoglobulin A resistance reinfection Schistosoma haematobium chemotherapy.
Interleukin-4, interferon-gamma interleukin-5 peripheral blood children moderate atopic asthma.
Interleukin-4, interleukin-10, interleukin-1-receptor antagonist transforming growth factor-beta stimulate ramification reduce adhesion molecule expression rat microglial cells.
Interleukin-4, interleukin-10, soluble tumor necrosis factor receptors cord blood.
Interleukin-4, interleukin-5, granulocyte-macrophage colony-stimulating factor receptor expression chronic sinusitis answer topical steroids.
Interleukin-4, interleukin-8 E-selectin levels intranasal polyposis patients allergy. comparative study.
Interleukin-4, transforming growth factor beta-1 dexamethasone inhibit superantigen-induced prostaglandin E-2-dependent collagenase gene expression effect cyclooxygenase-2 cytosolic phospholipase A-2.
Interleukin-4- 13-induced hypercontractility human intestinal muscle cells- implication motility Crohn's disease.
Interleukin-4-lacking BALB.
Interleukin-4-dependent immunoglobulin G1 isotype switch presence polarized antigen-specific Th1-cell answer trypanosome variant surface glycoprotein.
Interleukin-4-dependent induction preproenkephalin antigen-specific T helper-type 2 (Th2) cells.
Interleukin-4-dependent innate collaboration iNKT cells B-1B cells controls adaptative contact sensitivity.
Interleukin-4-dependent production PPAR-c ligands macrophages 12/15-lipoxygenase.
Interleukin-4-dependent production PPAR-gamma ligands macrophages 12/15-lipoxygenase.
Interleukin-4-dependent pulmonary eosinophil infiltration murine model asthma.
Interleukin-4-expressing plasmid DNA inhibits reovirus type-2-triggered autoimmune insulitis DBA/1 J suckling mice.
Interleukin-4-independent acceleration cutaneous leishmaniasis vulnerable BALB/c mice cure anti-CTLA4 antibody.
Interleukin-4-induced macrophage fusion prevented inhibitors mannose receptor activity.
Interleukin-4-inhibited mRNA expression mixed rat glial extracted microglial cultures.
Interleukin-4-mediated downregulation cytotoxic T lymphocyte activity reduced proliferation antigen-specific CD8+ T cells.
Interleukin-4-mediated inhibition C-Fos mRNA expression - Role lipoxygenase directed pathway.
Interleukin-4-mediated inhibition nitric oxide production interferon-gamma-treated virus-infected macrophages.
Interleukin-4-positive mast cells highly extent allergic wheal response skin.
Interleukin-4-producing CD4+ NK1.1+ TCR-alpha/beta-intermediate liver lymphocytes down-regulated Listeria monocytogenes.
Interleukin-4-transgenic hu-PBL-SCID mice. model screening antiviral drugs immunotherapeutic agents X4 HIV-1 viruses.
Interleukin-4-triggered, STAT6-dependent production factor induces mouse mast cell apoptosis.
Interleukin-4 - From B-lymphocyte fibroblast.
Interleukin-4 - production mast cell lines non-B, non-T cells.
Interleukin-5.
Interleukin-5 Is Predominant Cytokine Produced Peripheral Blood Mononuclear Cells Alveolar Echinococcosis.
Interleukin-5 Receptor Subunit Oligomerization Rearrangement Revealed Fluorescence Resonance Energy Transfer Imaging.
Interleukin-5 Receptor CD5-Positive B Cells.
Interleukin-5 eosinophil cationic protein nasal lavages rhinitis patients.
Interleukin-5 eosinophils therapeutic targets asthma.
Interleukin-5 eosinophils stimulate airway damage bronchial hyperreactivity allergic airway inflammation BALB/c mice.
Interleukin-5 human B lymphocytes.
Interleukin-5 binds heparin/heparan sulfate - model interaction extracellular matrix.
Interleukin-5 effect differential transcription transmembrane soluble isoforms IL-5R alpha vivo.
Interleukin-5 enhances eosinophil adhesion bronchial epithelial cells.
Interleukin-5 expressed recombinant virus vector enhances mucosal IgA responses vivo.
Interleukin-5 immunoreactivity mRNA expression gut mucosa patients food allergy.
Interleukin-5 growth differentiation blood eosinophil progenitors asthma - Influence glucocorticoids.
Interleukin-5 inhibition biliary cell chloride currents bile flow.
Interleukin-5 involvement ovalbumin-induced eosinophil infiltration mouse food-allergy model.
Interleukin-5 eosinophilia stimulated cyclophosphamide immunized mice.
Interleukin-5 mRNA expressed eosinophils gamma / delta T cells parasite-immune sheep.
Interleukin-5 mRNA expressed eosinophils gamma/delta T cells parasite-immune sheep.
Interleukin-5 mRNA T-cell lymphomas eosinophilia.
Interleukin-5 mRNA levels blood bone marrow mononuclear cells patients idiopathic hypereosinophilic syndrome.
Interleukin-5 messenger RNA immunoreactive protein expression activated eosinophils lesional atopic dermatitis skin.
Interleukin-5 messenger RNA expression peripheral blood CD4+ cells asthma.
Interleukin-5 modulates interleukin-8 secretion eosinophilic inflammation.
Interleukin-5 participates pathogenesis ileitis SAMP1/Yit mice.
Interleukin-5 potentiates sulfidopeptide leukotriene production human eosinophils.
Interleukin-5 potentiates growth answer Caco-2 cells IGF-II. function colonic carcinogenesis complicating ulcerative colitis?
Interleukin-5 priming human eosinophils alters Siglec-8-mediated apoptosis pathways.
Interleukin-5 production mononuclear cells aged individuals - Implication autoimmunity.
Interleukin-5 receptor alpha chain mRNA down-regulated transforming growth factor beta 1.
Interleukin-5 receptor endocytosis regulated distinct pathways.
Interleukin-5 receptor subunit oligomerization rearrangement revealed fluorescence resonance energy transfer imaging.
Interleukin-5 receptors human lung eosinophils segmental allergen challenge.
Interleukin-5 reduces expression uteroglobin-related protein (UGRP) 1 gene allergic airway inflammation.
Interleukin-5 regulates genes involved B-cell terminal maturation.
Interleukin-5 transgenic mice show enhanced resistance primary infections Nippostrongylus brasiliensis primary infections Toxocara canis.
Interleukin-5 upregulates intercellular adhesion molecule-1 gene expression nasal mucosa nasal allergy nonallergic rhinitis.
Interleukin-5, eosinophils control helminth infections man laboratory animals.
Interleukin-5, interleukin-3 granulocyte-macrophage colony-stimulating factor prime actin-polymerization human eosinophils. study hypodense normodense eosinophils patients atopic dermatitis.
Interleukin-5-induced generation superoxide eosinophils asthma.
Interleukin-6 (IL-6) IGF-IGFBP scheme children adolescents type 1 diabetes mellitus.
Interleukin-6 (IL-6) IL-8 stimulated human oral epithelial cells answer exposure periodontopathic Eikenella corrodens.
Interleukin-6 (IL-6) soluble receptor support survival sensory neurons.
Interleukin-6 (IL-6) O-2 concentration (1%) synergize improving maintenance hematopoietic stem cells (Pre-CFC).
Interleukin-6 (IL-6) receptor (IL6-R) gene haplotypes associate amniotic fluid protein concentrations preterm birth.
Interleukin-6 (IL-6) soluble forms IL-6 receptors altered cerebrospinal fluid Alzheimer's disease patients.
Interleukin-6 (IL-6) and/or Soluble IL-6 Receptor Down-regulation Human Type II Collagen Gene Expression Articular Chondrocytes Requires Decrease Sp1.Sp3 Ratio Binding Activity Both Factors COL2A1 Promoter.
Interleukin-6 (IL-6) and/or soluble IL-6 receptor down-regulation human type II collagen gene expression articular Chondrocytes requires decrease Sp1 center dot Sp3 ratio binding activity factors COL2A1 promoter.
Interleukin-6 (IL-6) functions autocrine growth factor cervical carcinomas vitro.
Interleukin-6 (IL-6) patients Behcet's disease.
Interleukin-6 (IL-6) induces proliferation synovial fibroblastic cells presence soluble IL-6 receptor.
Interleukin-6 (IL-6) secreted brain intracerebroventricular injection IL-1-beta rats.
Interleukin-6 (IL-6) secreted brain intracerebroventricular injection IL-1b rats.
Interleukin-6 (IL-6) leading biomarker metabolic aging similar disorders.
Interleukin-6 (IL-6) modulates migration matrix metalloproteinase role dermal fibroblasts IL-6KO mice.
Interleukin-6 (IL-6) producing phaeochromocytoma - Direct IL-6 suppression non-steroidal anti-inflammatory drugs.
Interleukin-6 (IL-6) production cell growth cultured human meningiomas:- interactions interleukin-1-beta (IL-1-beta) interleukin-4 (IL-4) vitro.
Interleukin-6 (IL-6) production mice infested Trypanosoma cruzi - Influence paradoxical increase anti-IL-6 monoclonal antibody cure infection acute-phase humoral immune responses.
Interleukin-6 (IL-6) production mice infested Trypanosoma cruzi - influence paradoxical increase anti-IL-6 monoclonal antibody cure infection acute-phase humoral immune responses.
Interleukin-6 (IL-6)-174 G/C polymorphism familial Mediterranean fever patients amyloidosis.
Interleukin-6 (IL-6)-373 A9T11 allele reduced vulnerability chronic periodontitis Japanese subjects decreased serum IL-6 degree.
Interleukin-6 (IL6) cellular answer facial nerve injury - Influences lymphocyte recruitment, early microglial activation axonal outgrowth IL6-lacking mice.
Interleukin-6: 174G/C polymorphism longevity. follow-up study.
Interleukin-6 Biosynthesis in Human Preovulatory Follicles: Some of its Potential Roles at Ovulation
Interleukin-6 Directly Inhibits Osteoclast Differentiation Suppressing Receptor Activator NF-kB Signaling Pathways.
Interleukin-6 Gene Polymorphism -174G.
Interleukin-6 Induces G1, arrest induction p27Kip1 cyclin-dependent kinase inhibitor, neuron-like morphology LNCaP prostate tumor cells.
Interleukin-6 Inhibits Apoptosis Malignant Plasma Cells.
Interleukin-6 N-terminal peptides modulate expression junB protooncogene production fibrinogen HepG2 cells.
Interleukin-6 Regulation Transforming Growth Factor (TGF)-b Receptor Compartmentalization Turnover Enhances TGF-b1 Signaling.
Interleukin-6 activates P13K/Akt pathway regulates cyclin A1 promote prostate cancer cell survival.
Interleukin-6 activates phosphatidylinositol-3 kinase, inhibits apoptosis human prostate cancer cell lines.
Interleukin-6 activates phosphoinositol-30 kinase multiple myeloma tumor cells signaling RAS-dependent and, separately, p85-dependent pathways.
Interleukin-6 activates signal transducer activator transcription mitogen-activated protein kinase signal transduction pathways induces de novo protein synthesis human neuronal cells.
Interleukin-6 activation ischemic stroke attributable Neisseria meningitidis serogroup C.
Interleukin-6 activity dogs juvenile polyarteritis syndrome - Influence corticosteroids.
Interleukin-6 activity dogs juvenile polyarteritis syndrome - effects corticosteroids.
Interleukin-6 activity wounds.
Interleukin-6 acts antiapoptotic factor human esophageal carcinoma cells activation STAT3 mitogen-activated protein kinase pathways.
Interleukin-6 acts insulin sensitizer glycogen synthesis human skeletal muscle cells phosphorylation Ser473 Akt.
Interleukin-6 acts diverse ways soluble membrane-bound receptor.
Interleukin-6 affects melphalan-induced DNA damage repair human multiple myeloma cells.
Interleukin-6 affects scopolamine-induced amnesia, but not brain amino acid levels in mice.
Interleukin-6 alters sleep rats.
Interleukin-6 alters cellular responsiveness clopidogrel, irinotecan, Oseltamivir suppressing expression Carboxylesterases HCE1 HCE2.
Interleukin-6 B-type natriuretic peptide independent predictors worsening heart failure patients progressive congestive heart failure.
Interleukin-6 C-reactive protein serum levels sepsis-related fatalities early postmortem period.
Interleukin-6 CAAT/enhancer binding protein beta-lacking mice act tools dissect IL-6 signalling pathway IL-6 regulation.
Interleukin-6 IL-6 receptor cell expression testis rats autoimmune orchitis.
Interleukin-6 Interleukin-8 Extraction During Continuous Venovenous Hemodiafiltration Septic Acute Renal Failure.
Interleukin-6 STAT3 protect liver hepatic ischemia reperfusion injury ischemic preconditioning.
Interleukin-6 TNF alpha production human renal cell carcinoma.
Interleukin-6 Tumor Necrosis Factor-alpha Values Elk Neonates.
Interleukin-6 acute coronary syndrome.
Interleukin-6 acute-phase protein concentrations surgical intensive care unit patients - Diagnostic signs nosocomial infection.
Interleukin-6 aging - Blood levels mononuclear cell production increase advancing age vitro production modifiable dietary restriction.
Interleukin-6 antiphospholipid antibodies women contraceptive-related thromboembolic disease.
Interleukin-6 cachexia ApcMin/+ mice.
Interleukin-6 cardiovascular diseases.
Interleukin-6 chemokines neuropsychiatric manifestations systemic lupus erythematosus.
Interleukin-6 ciliary neurotrophic factor trigger Janus kinase activation early gene answer rat hepatocytes.
Interleukin-6 complex cardiac myxoma.
Interleukin-6 corticotrophin-releasing hormone mRNA modulated differentiation human neuroblastoma cells.
Interleukin-6 dexamethasone modulate vitro asymmetric antibody synthesis UDP-Glc glycoprotein glycosyltransferase activity.
Interleukin-6 dexamethasone work coordinately augment hepatic amino acid transport.
Interleukin-6 disease severity patients bacteremic nonbacteremic febrile urinary tract infection.
Interleukin-6 epidermal growth factor promote anchorage-independent growth immortalized human prostatic epithelial cells treated N-methyl-N-nitrosourea.
Interleukin-6 erythropoietin act direct potentiators inducers vitro cytoplasmic process structure purified mouse megakaryocytes.
Interleukin-6 glucocorticoids synergistically stimulate human immunoinsufficiency virus type-1 expression chronically infested U1 cells long terminal repeat independent post-transcriptional mechanism.
Interleukin-6 glucocorticosteroid responses cardiopulmonary bypass.
Interleukin-6 granulocyte colony-stimulating factor synergistically increase peripheral blood progenitor cells myelosuppressive mice.
Interleukin-6 granulocyte-macrophage colony-stimulating factor apical periodontitis - Correlation medical histologic findings involved teeth.
Interleukin-6 human immunoinsufficiency virus load, plasma leptin concentration, predict anorexia wasting adults pulmonary tuberculosis Malawi.
Interleukin-6 immune condition children nephrotic syndrome.
Interleukin-6 insulin-like growth factor scheme relationships differences human placenta fetus week gestation.
Interleukin-6 interferon-gamma gene polymorphisms progress bronchiolitis obliterans syndrome lung transplantation.
Interleukin-6 interieukin-6 promoter polymorphism (-174) G > C patients spontaneous venous thromboembolism.
Interleukin-6 interleukin- 15 selectively regulated lipopolysaccharide interferon-c primary swine adipocytes.
Interleukin-6 interleukin-1 receptor antagonist acute stroke.
Interleukin-6 interleukin-1 receptor antagonist cerebrospinal fluid patients tonic-clonic seizures.
Interleukin-6 interleukin-1-alpha production antigen-induced late nasal answer.
Interleukin-6 interleukin-10 expressed organs normal young mice.
Interleukin-6 interleukin-10 cerebrospinal fluid severe traumatic brain injury children.
Interleukin-6 interleukin-11 support human osteoclast structure RANKL-independent mechanism.
Interleukin-6 interleukin-12 participate induction type 1 protective T-cell answer vaccination tuberculosis subunit vaccine.
Interleukin-6 interleukin-15 selectively regulated lipopolysaccharide interferon- gamma primary swine adipocytes.
Interleukin-6 interleukin-15 selectively regulated lipopolysaccharide interferon-gamma primary swine adipocytes.
Interleukin-6 interleukin-6 receptor expressed cultured glomerular epithelial cells.
Interleukin-6 interleukin-6 receptor secretion chronic lymphatic leukaemia normal B lymphocytes - Influence PMA PWM.
Interleukin-6 interleukin-6 soluble receptor regulate proliferation normal, human papillomavirus-immortalized, carcinoma-derived cervical cells vitro.
Interleukin-6 interleukin-8 elevated cerebrospinal fluid infants exposed chorioamnionitis.
Interleukin-6 interleukin-8 concentrations predictors outcome ventricular assist device patients heart transplantation.
Interleukin-6 interleukin-8 cervical amniotic fluid - relation microbial invasion chorioamniotic membranes.
Interleukin-6 interleukin-8 newborn bacterial infection.
Interleukin-6 interleukin-8 production mononuclear cells chronic alcoholics cure.
Interleukin-6 interleukin-8 protein gene expression human arterial atherosclerotic wall.
Interleukin-6 interstitial cystitis.
Interleukin-6 and its mRNA responses in exercise and recovery: relationship to muscle glycogen.
Interleukin-6 receptor cancer: Implications translational therapeutics.
Interleukin-6 relationships acute phase proteins serous effusion differentiation.
Interleukin-6 soluble receptor acute meningococcal infections - Influence plasma blood exchange.
Interleukin-6 soluble receptor bone tumors.
Interleukin-6 and its soluble receptor in serum and cerebrospinal fluid after cerebral trauma.
Interleukin-6 soluble receptors human breast cancer.
Interleukin-6 neopterin levels serum patients preterm labour infection.
Interleukin-6 nerve growth factor levels peripheral nerve brainstem trigeminal nerve injury rat.
Interleukin-6 nerve growth factor upregulation correlates good outcome children severe traumatic brain injury.
Interleukin-6 nitric oxide synthase expression vasopressin corticotrophin-releasing factor systems rat hypothalamus.
Interleukin-6 oligoclonal IgG synthesis children acute disseminated encephalomyelitis.
Interleukin-6 oncostatin M stimulation proliferation prostate cancer 22Rv1 cells signaling pathways p38 mitogen-activated protein kinase phosphatidylinositol 3-kinase.
Interleukin-6 oncostatin M-induced growth inhibition human A375 melanoma cells STAT-dependent involves upregulation cyclin-dependent kinase inhibitor p27/Kip1.
Interleukin-6 osteoprotegerin systems Paget's disease bone - relation risedronate cure.
Interleukin-6 gp130-dependent cytokines selectively inhibit proliferation macrophage-lineage hemopoietic progenitor cells.
Interleukin-6 perioperative thermoregulation HPA-axis activation.
Interleukin-6 procalcitonin serum children undergoing cardiac surgery cardiopulmonary bypass.
Interleukin-6 and risk of cognitive decline: MacArthur studies of successful aging.
Interleukin-6 selected plasma proteins healthy persons diverse ages.
Interleukin-6 soluble intercellular adhesion molecule-1 acute brain ischaemia.
Interleukin-6 soluble interleukin-6 receptor peritoneal fluid serum patients endometriosis.
Interleukin-6 soluble interleukin-6 receptor colonic mucosa inflammatory bowel disease.
Interleukin-6 soluble interleukin-6 receptor serum levels recurrent spontaneous abortion women immunized paternal white cells.
Interleukin-6 soluble interleukin-6 receptors synovial fluids rheumatoid arthritis patients responsible osteoclast-like cell structure.
Interleukin-6 Acute Phase Response Treatment Patients Paget's Disease Nitrogen-Containing Bisphosphonate Dimethylaminohydroxypropylidene Bisphosphonate.
Interleukin-6 progress social disruption-induced glucocorticoid resistance.
Interleukin-6 network cytokines multiple myeloma - An overview medical experimental data.
Interleukin-6 risk future cardiovascular events patients angina pectoris and/or healed myocardial infarction.
Interleukin-6 skin.
Interleukin-6 soluble IL-6 receptor decreased cerebrospinal fluid geriatric patients major depression - No alteration soluble gp130.
Interleukin-6 soluble interleukin-6 receptor stimulate stem cell factor Flt-3L expression vivo vitro.
Interleukin-6 transforming growth factor-b regulate expression monocyte chemoattractant protein-1 colony-stimulating factors human thyroid follicular cells.
Interleukin-6 transforming growth factor-b synergistically induce chondrosarcoma cell proliferation.
Interleukin-6 transforming growth factor-beta regulate expression monocyte chemoattractant protein-1 colony-stimulating factors human thyroid follicular cells.
Interleukin-6 transforming growth factor-beta-1 mRNAs stimulated rat facial nucleus motoneuron axotomy.
Interleukin-6 transforming growth factor-beta1 control expression cathepsins B L human lung epithelial cells.
Interleukin-6 tumor necrosis factor alpha predictors success emergent cerclage.
Interleukin-6 tumor necrosis factor alpha levels bisphosphonates cure vitro patients malignancy.
Interleukin-6 tumor necrosis factor cerebrospinal fluid - Changes pyrogen fever.
Interleukin-6 tumor necrosis factor pathogenesis adverse reactions cure lymphatic filariasis onchocerciasis.
Interleukin-6 tumor necrosis factor-alpha clearance metabolism vivo isolated, perfused liver rat - Influence acute alcohol administration.
Interleukin-6 tumor necrosis factor-alpha concentrations intrauterine cavity postmenopausal women intrauterine delivery scheme releasing progesterone. potential mechanism effect intrauterine device.
Interleukin-6 tumor necrosis factor-alpha sera patients pemphigus.
Interleukin-6 tumor necrosis factor-alpha levels plasma cerebrospinal fluid term newborn infants hypoxic-ischemic encephalopathy.
Interleukin-6 tumor necrosis factor-alpha levels increase answer maximal exercise patients chronic heart failure.
Interleukin-6 tumor necrosis factor-alpha type 1 receptor deficient mice reveal function IL-6 TNF-alpha brain metallothionein-I -III regulation.
Interleukin-6 tumor necrosis factor-alpha values elk neonates.
Interleukin-6 tumour necrosis factor alpha synergistically block S-phase cell cycle upregulate intercellular adhesions molecule-1 expression MCF7 breast carcinoma cells.
Interleukin-6 and tumour necrosis factor in synovial fluid from horses with carpal joint pathology.
Interleukin-6 tumour necrosis factor levels decrease suction blister fluids psoriatic patients effective therapy.
Interleukin-6 vascular endothelial growth factor release renal cell carcinoma cells impedes lymphocyte-dendritic cell cross-talk.
Interleukin-6 antagonists manipulation hypertension.
Interleukin-6 a mediator cardiovascular risk chronic inflammation, smoking, diabetes, visceral obesity - Down-regulation essential fatty acids, ethanol pentoxifylline.
Interleukin-6 marker hepatic metabolism hepatectomy.
Interleukin-6 mediator responsible inflammation-induced increase plasma angiotensinogen.
Interleukin-6 paracrine autocrine growth factor human prostatic carcinoma cells vitro.
Interleukin-6 attenuates hyperthermia-induced seizures developing rats.
Interleukin-6 augments hepatocyte growth factor-induced liver regeneration; Involvement STAT3 activation.
Interleukin-6 augments neutrophil cytotoxic potential selective enhancement elastase release.
Interleukin-6 autoantibodies - Possible biological medical significance.
Interleukin-6 biology coordinated membrane bound soluble receptors.
Interleukin-6 biology coordinated membrane-bound soluble receptors - function inflammation cancer.
Interleukin-6 biosynthesis increased histamine human B-cell glioblastoma cell lines.
Interleukin-6 cDNA transfected Lewis lung carcinoma cells unaltered net tumour growth rate volume loss shorten survival syngenic mice.
Interleukin-6 endothelial barrier dysfunction protein kinase C pathway.
Interleukin-6 concentrations cervical secretions identify microbial invasion amniotic cavity patients preterm labor intact membranes.
Interleukin-6 concentrations cervical secretions prediction intrauterine infection preterm premature rupture membranes.
Interleukin-6 concentrations neonates evaluated sepsis.
Interleukin-6 concentrations placenta blood normal pregnancies preeclampsia.
Interleukin-6 concentrations umbilical cord plasma elevated neonates white matter lesions periventricular leukomalacia.
Interleukin-6 contributes Mcl-1 up-regulation TRAIL resistance Akt-signaling pathway cholangiocarcinoma cells.
Interleukin-6 contributes age-related alteration cytokine production macrophages.
Interleukin-6 contributes growth cholangiocarcinoma cells aberrant promoter methylation gene expression.
Interleukin-6 correlates endothelial dysfunction young post-myocardial infarction patients.
Interleukin-6 correlates hemodynamic impairment dobutamine administration chronic heart failure.
Interleukin-6 decreases senescence increases telomerase activity malignant human cholangiocytes.
Interleukin-6 insufficiency increases blood volume altering body composition young mice.
Interleukin-6 insufficiency increases inflammatory bone destruction.
Interleukin-6 insufficiency reduces brain inflammatory answer increases oxidative stress neurodegeneration kainic acid-induced seizures.
Interleukin-6 delays neutrophil apoptosis mechanism involving platelet-activating factor.
Interleukin-6 dependent induction cyclin dependent kinase inhibitor p21WAF1/CIP1 lost progression human malignant melanoma.
Interleukin-6 derived hypoxic myocytes promotes neutrophil-mediated reperfusion injury myocardium.
Interleukin-6 differentially regulates androgen receptor transactivation PI3K-Akt, STAT3, MAPK, distinct signal pathways prostate cancer cells.
Interleukin-6 increases glucose metabolism resting human skeletal muscle.
Interleukin-6 directly influences proliferation and invasion potential of head and neck cancer cells
Interleukin-6 inhibits osteoclast differentiation suppressing receptor activator NF-kappa B signaling pathways.
Interleukin-6 activate protein breakdown rat skeletal muscle.
Interleukin-6 mediate endotoxin-induced uveitis mice - Investigations gene deletion animals.
Interleukin-6 regulate interstitial collagenase, stromelysin tissue inhibitor metalloproteinases synthesis cultured human fibroblasts.
Interleukin-6 induce rat myometrial contractions vitro model.
Interleukin-6 down-regulates expression aldolase B albumin genes pathway involving activation tyrosine kinase.
Interleukin-6 influence hematopoietic restoration rats exposed mixed neutron-gamma radiation.
Interleukin-6 enhances expression adenosine A1 receptor mRNA signaling cultured rat cortical astrocytes brain slices.
Interleukin-6 enhances glucose transport 3T3-L1 adipocytes.
Interleukin-6 enhances hepatic transferrin absorption ferritin expression rats.
Interleukin-6 enhances hypercalcemia bone resorption mediated parathyroid hormone-related protein vivo.
Interleukin-6 enhances tumor necrosis factor alpha interferons inhibit integrin expression adhesion human mast cells extracellular matrix proteins.
Interleukin-6 exacerbates glomerulonephritis (NZB X NZW)F-1 mice.
Interleukin-6 expression infectious bronchitis virus infection chickens.
Interleukin-6 expression repeated bouts eccentric exercise.
Interleukin-6 expression histomorphometry bones mice deficient receptors interleukin-1 tumor necrosis factor.
Interleukin-6 expression regulation astrocytes.
Interleukin-6 expression regulation rat enteric glial cells.
Interleukin-6 expression normal maturation mouse testis.
Interleukin-6 expression chronic sinusitis - Colocalization gene transcripts eosinophils, macrophages, T lymphocytes, mast cells.
Interleukin-6 expression cord blood patients medical chorioamnionitis.
Interleukin-6 expression in exo-focal neurons after striatal cerebral ischemia.
Interleukin-6 expression human multiple sclerosis lesions.
Interleukin-6 expression immunologically elicited murine macrophages.
Interleukin-6 facilitates lipopolysaccharide-induced disruption working memory expression proinflammatory cytokines hippocampal neuronal cell layers.
Interleukin-6 family cytokines - Signaling effects human airway smooth muscle cells.
Interleukin-6 family cytokines - signaling effects human airway smooth muscle cells.
Interleukin-6 family cytokines biochemical markers osseous temporomandibular joint disorders.
Interleukin-6 intrahepatic cells bone marrow origin required normal murine liver regeneration.
Interleukin-6 functions autocrine growth factor cholangiocarcinoma cell line.
Interleukin-6 functions autocrine growth factor human bladder carcinoma cell lines vitro.
Interleukin-6 functions autocrine growth stimulator human lung adenocarcinoma cell line PAa.
Interleukin-6 functions autoimmune encephalomyelitis. study gene-targeted mice.
Interleukin-6 g.-174G>C promoter polymorphism obesity EPIC-Potsdam Investigation.
Interleukin-6 gene alleles affect risk Alzheimer's disease levels cytokine blood brain.
Interleukin-6 gene amplification shortened survival glioblastoma patients.
Interleukin-6 gene expression increased insulin-resistant rat skeletal muscle insulin stimulation.
Interleukin-6 gene expression preferentially restricted VLA-5-MPC-1- immature VLA-5+MPC-1+ mature myeloma cells.
Interleukin-6 gene polymorphism faster progression end-stage renal failure chronic glomerulonephritis.
Interleukin-6 gene polymorphism age-dependent risk factor myocardial infarction men.
Interleukin-6 gene polymorphism similar bone mineral density puberty healthy white males. cross-sectional longitudinal study.
Interleukin-6 gene promoter -174G/C polymorphism and insulin resistance: a pilot study.
Interleukin-6 gene promoter-174G/C polymorphism and insulin resistance: a pilot study.
Interleukin-6 gene variants risk sepsis progress children.
Interleukin-6 gene variation Spanish patients immunoglobulin-A insufficiency.
Interleukin-6 gene-lacking mice show impaired defense pneumococcal pneumonia.
Interleukin-6 genetic ablation protects trinitrobenzene sulfonic acid-induced colitis mice: Putative influence antiinflammatory cytokines.
Interleukin-6 genetic polymorphism Chinese major depression.
Interleukin-6 genetic polymorphisms similar Helicobacter pylori-associated gastroduodenal diseases.
Interleukin-6 genetic inconsistency adiposity - Associations prospective cohorts systematic review 26,944 individuals.
Interleukin-6 genotype high-density lipoprotein cholesterol responses exercise training.
Interleukin-6 differential effect ability adjuvant formulations potentiate antibody reponses Plasmodium falciparum blood-stage vaccine.
Interleukin-6 impairs endothelium-dependent NO-cGMP-mediated relaxation enhances contraction systemic vessels pregnant rats.
Interleukin-6 implication prostate cancer.
Interleukin-6 amniotic fluid attained forewater amniotomy compared hindwater samples women spontaneous labour.
Interleukin-6 bronchoalveolar lavage fluid patients COPD.
Interleukin-6 cerebrospinal fluid patients with nervous scheme infections.
Interleukin-6 cervical cancer - The relation vascular endothelial growth factor.
Interleukin-6 chronic liver diseases.
Interleukin-6 combination soluble IL-6 receptor sensitises rat skin nociceptors heat, vivo.
Interleukin-6 differently modulated by opioid receptor subtypes.
Interleukin-6 experimental endometriosis.
Interleukin-6 hepatitis C cirrhosis.
Interleukin-6 human milk.
Interleukin-6 relationship proinflammatory cytokines, chemotactic activity neutrophil activation rheumatoid synovial fluid.
Interleukin-6 renal cell carcinoma.
Interleukin-6 retinal ischemia reperfusion injury rats.
Interleukin-6 seminal plasma fertile infertile men.
Interleukin-6 synovial fluid HLA-DR expression synovium patients temporomandibular disorders.
Interleukin-6 in synovial fluid is closely associated with chronic synovitis in rheumatoid arthritis
Interleukin-6 aging brain.
Interleukin-6 the nervous scheme.
Interleukin-6 cerebrospinal fluid patients herpes zoster meningitis.
Interleukin-6 fever multiorgan crisis pheochromocytoma.
Interleukin-6 transcatheter arterial embolization patients hepatocellular carcinoma.
Interleukin-6 increases carcinoembryonic antigen histocompatibility leukocyte antigen expression surface human colorectal carcinoma cells.
Interleukin-6 increases insulin-stimulated glucose disposal humans glucose absorption fatty acid oxidation vitro AMP-activated protein kinase.
Interleukin-6 increases rat metalloproteinase-13 gene expression Janus kinase-2-mediated inhibition serine/threonine phosphatase-2A.
Interleukin-6 increases levels cyclic GMP nitrite rat hippocampal slices.
Interleukin-6 increases survival retinal ganglion cells vitro.
Interleukin-6 increases thrombopoietin production human hepatoma cells HepG2 Hep3B.
Interleukin-6 increases vascular endothelial growth factor angiogenesis gastric carcinoma.
Interleukin-6 independent regulation hepcidin anemia inflammation.
Interleukin-6 stimulated basic fibroblast growth factor-dependent angiogenesis basal cell carcinoma cell line JAK/STAT3 P13-Kinase/Akt pathways.